ADHD Myths vs. Facts

Fact: Yes and no—but clinically speaking, no.

Yes, ADHD exists on a spectrum in the sense that many people occasionally exhibit individual symptoms. For example, almost everyone has procrastinated on a difficult task at some point. However, for most people, the nature and severity of those symptoms do not cause significant, ongoing impairment to daily life functioning.

So, no—not everyone has ADHD. If everyone had it, no one would, nor would it have been recognized as a distinct neurodevelopmental disorder in the Diagnostic and Statistical Manual of Mental Disorders (DSM) for nearly 60 years.

Believing this myth undermines the real impairment experienced by those diagnosed. It increases stigma and causes generations of people to refrain from seeking the help they desperately need. When ADHD symptoms become maladaptive enough to impair regular functioning, this "hidden disability" becomes all-pervasive, impacting every domain of life.

Understanding this distinction highlights the vital need for accurate diagnostic protocols and professional treatment options—including medication, coaching, and psychology. It is neither accurate nor helpful to rely on social media screening questionnaires for a diagnosis. While online quizzes can prompt uncertain individuals to seek professional guidance, a formal assessment remains essential.

Fact: No. ADHD medication does not act as a test-score enhancer for neurotypical brains.

Research confirms that when individuals without ADHD take stimulant medication prior to an exam, their performance is actually poorer than if they had not taken it. Conversely, individuals with ADHD who take prescribed medication perform significantly better on university and college examinations than when they go unmedicated.

Fact: ADHD is a lifelong neurodevelopmental condition.

While this was once the prevailing view, clinical consensus now recognizes ADHD as a lifelong disorder. Over time, individuals may develop effective coping mechanisms, find suitable career paths, or deploy workarounds to limit its impact, but the underlying neurodivergence persists across the lifespan.

Furthermore, symptom severity often shifts during major hormonal transitions. This is especially true for perimenopausal women, many of whom are only diagnosed when fluctuating hormones cause their symptoms to become significantly maladaptive later in life.

Fact: Not everyone with ADHD is hyperactive.

Many individuals present with the Predominantly Inattentive type, struggling with internal distraction, forgetfulness, and severe mental fatigue rather than "bouncing off the walls".

In total, there are three primary presentations of ADHD:

• Hyperactive-Impulsive Presentation

• Inattentive Presentation

• Combined Presentation

Fact: Parenting styles do not cause ADHD.

Extensive scientific research demonstrates that ADHD has a powerful genetic and biological foundation. Literature frequently cites the heritability of ADHD at approximately 0.85—a rate directly comparable to physical height (cited around 0.90), which is one of the most heritable traits known.

Fact: Procrastination and disorganisation stem from neurological executive dysfunction, not a lack of willpower.

The executive function network is the brain’s control center for planning, focus, initiation, and self-regulation. Well-meaning advice like "Why don't you just decide to do it?" fails to account for these neurological differences. Far from helping, such comments usually cause the individual to feel misunderstood and shut down.

Fact: Women and girls experience ADHD at the exact same rates as men and boys.

Historically, women and girls have been severely underdiagnosed because their symptoms tend to present as quiet inattentiveness rather than disruptive physical hyperactivity. Additionally, girls often develop strong masking mechanisms throughout their early years and into young adulthood.

Because symptom severity often spikes during perimenopause due to hormonal changes, many women only receive a diagnosis in their 30s, 40s, or 50s.

Fact: Taken as prescribed, stimulant medication for ADHD does not increase the risk of substance addiction.

In fact, research shows that individuals with undiagnosed and untreated ADHD have a significantly higher rate of self-medicating with addictive substances (such as alcohol, nicotine, cannabis, and illicit drugs) to manage their unaddressed symptoms.

That said, appropriate management of prescribed medication remains important. Parents, carers, and support networks should remain involved in monitoring dosage and consistency, and practical scaffolding around medication routines is always recommended for young people.

Fact: Diagnostic and prescribing rules vary across Australia, and primary care access is expanding.

Historically, regulations differed significantly by state. Psychiatrists (for adults over 18) and Paediatricians (under 18) have traditionally been the primary specialists authorized to prescribe ADHD medications, while Clinical Psychologists have long been able to assess and diagnose—but not prescribe.

However, access pathways are expanding:

• In states like Queensland, trained General Practitioners (GPs) and Nurse Practitioners have assisted in prescribing and managing ADHD care for years.

• Across an increasing number of Australian states (including NSW), relevant health authorities have updated regulations to allow specialized GPs who have completed accredited training to assess, diagnose, and prescribe ADHD medications.